Adam 1996.

Methods	RCT
Participants	German multicentre trial of children 3 months to 6 years old
Interventions	Cefpodoxime 40 mg to 60 mg twice daily for 5 days versus cefaclor 40 mg/kg/day 3 times daily for 10 days
Outcomes	Absence or improvement of signs and symptoms at 3 days and no relapse at 3 weeks after study entry
Notes	—
Risk of bias
Bias	Authors' judgement	Support for judgement
Blinding (performance bias and detection bias) Treatment failure at 1 month or less	High risk
Incomplete outcome data (attrition bias) Treatment failure at 1 month or less	Low risk
Selective reporting (reporting bias)	Low risk
Other bias	Unclear risk	Funding not reported